BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu J, Cao W, Shao A, Yang M, Andoh V, Ge Q, Pan H, Chen K, Chiaradonna F. Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy. BioMed Research International 2022;2022:1-24. [DOI: 10.1155/2022/7819235] [Reference Citation Analysis]
2 Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Curr Treat Options Oncol 2022. [PMID: 35511346 DOI: 10.1007/s11864-022-00986-w] [Reference Citation Analysis]
3 Ronellenfitsch U, Klose J, Kleeff J. Multimodal Therapy of Upper Gastrointestinal Malignancies. Cancers (Basel) 2021;13:793. [PMID: 33672858 DOI: 10.3390/cancers13040793] [Reference Citation Analysis]
4 Didamson OC, Abrahamse H. Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine. Pharmaceutics 2021;13:1943. [PMID: 34834358 DOI: 10.3390/pharmaceutics13111943] [Reference Citation Analysis]
5 Dhruv S, Anwar S, Polavarapu A, Liliane D. Gastric Carcinoid: The Invisible Tumor! Cureus 2021;13:e13556. [PMID: 33791175 DOI: 10.7759/cureus.13556] [Reference Citation Analysis]
6 Li X, Su X, Yan C, Ma Y, Li H, Xia J, Li H, Jiang Q, Zhou L, Zou Z. Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35767192 DOI: 10.1007/s00432-022-04122-x] [Reference Citation Analysis]
7 Tustumi F, Marques SSB, Barros EF, Henriques AC, Waisberg J, Dias AR. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY. Arq Gastroenterol 2022;59:53-7. [DOI: 10.1590/s0004-2803.202200001-10] [Reference Citation Analysis]
8 Waters JK, Reznik SI. Update on Management of Squamous Cell Esophageal Cancer. Curr Oncol Rep 2022. [PMID: 35142974 DOI: 10.1007/s11912-021-01153-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]